Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
54.00
-1.56 (-2.81%)
Nov 17, 2026, 3:04 PM CST

SHE:002653 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
1,304259.58395.46295.11277.07345.06
Depreciation & Amortization
273.5273.5249.22219.58184.12153.19
Other Amortization
9.889.885.472.914.293.1
Loss (Gain) From Sale of Assets
22.2722.27-31.10.2800.13
Asset Writedown & Restructuring Costs
11.3611.3683.1913.020.840.62
Loss (Gain) From Sale of Investments
17.1517.15-117.3960.47-227.72-420.77
Provision & Write-off of Bad Debts
-0.42-0.421.790.30.910.32
Other Operating Activities
-349.6432.41109.6142.13167.43202.79
Change in Accounts Receivable
139.81139.81-182.98-70.94-191.11-45.88
Change in Inventory
-35.93-35.9310.8266.19-90.38-36.29
Change in Accounts Payable
-52.06-52.06-82.55-352.48-4.41-264.99
Change in Other Net Operating Assets
130.08130.0829.75193.5114.82101.71
Operating Cash Flow
1,448786442.05449.5894.5535.8
Operating Cash Flow Growth
127.92%77.81%-1.68%375.51%164.08%-82.64%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-354.85-331.98-440.65-391.01-700.17-702.94
Sale of Property, Plant & Equipment
9.2213.4531.424.290.360.33
Divestitures
-00.3---180.16
Investment in Securities
-163.66151.1810.820.34159.62781.92
Other Investing Activities
16.1711.0796.813.190.322.5
Investing Cash Flow
-493.13-155.98-301.61-383.19-539.88281.97

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,0591,400898.362,000932.21
Short-Term Debt Repaid
------2.26
Long-Term Debt Repaid
--1,017-1,309-1,206-1,153-816.65
Lease Payments
-6.17-6.17-9.02-7.94-10.26-9.59
Total Debt Repaid
-1,147-1,017-1,309-1,206-1,153-818.91
Net Debt Issued (Repaid)
-48.3341.3590.38-307.16847.22113.3
Issuance of Common Stock
1,233-80.94793.64-23.76
Repurchase of Common Stock
----8.16-6.37-2.47
Common Dividends Paid
-925.13-333.15-422.04-42.57-247.49-426.21
Other Financing Activities
-12.22-0.390.05-107.6830.87104.38
Financing Cash Flow
247.43-292.18-250.68328.07624.23-187.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-30.41-6.864.87-1.5416.94-6.77
Net Cash Flow
1,172330.99-105.37392.92195.84123.77

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,093454.031.3958.57-605.62-667.14
Free Cash Flow Growth
380.96%32537.74%-97.63%---
Free Cash Flow Margin
18.04%10.35%0.04%1.75%-20.09%-24.06%
Free Cash Flow Per Share
0.970.400.000.05-0.57-0.62
Levered Free Cash Flow
1,020196.77-209.72-152.29-781.91-895.41
Unlevered Free Cash Flow
1,037217.1-186.08-125.87-750.09-878.44
Free Cash Flow After Leases
1,087447.86-7.6350.63-615.88-676.73

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
577.71382.37414.04329.11197.09173.38
Change in Working Capital
160.28160.28-254.19-184.24-312.4-248.64